Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Azenta, Inc. (AZTA) Guidance & Earnings Results

On 2026-08-04 Azenta, Inc. mixed guidance: "Q4 FY2026 organic revenue decline low single digits YoY; Adjusted EBITDA range not fully specified in…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AZTAAzenta, Inc.Follow AZTA — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
1.6B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
4 Aug 26MixedQ4 FY2026 organic revenue decline low single digits YoY; Adjusted EBITDA range not fully specified in excerpt
5 May 26LoweredFY'26 organic revenue -2% to +1% (from 3-5%); EBITDA margin -125bps to flat (from +300bps expansion) · full year
4 Feb 26ReaffirmedFY2026 objectives reaffirmed · full year
21 Nov 25RaisedFY2026 organic revenue growth 3-5% YoY; ~300bps Adjusted EBITDA margin expansion
5 Aug 25ReaffirmedFY2025 total organic revenue growth 3% to 5% relative to FY2024; FY2025 adjusted EBITDA margin expansion approximately 300 basis points relative to FY2024 · full year

Azenta, Inc. — questions

What guidance did Azenta, Inc. give?
On 2026-08-04: "Q4 FY2026 organic revenue decline low single digits YoY; Adjusted EBITDA range not fully specified in excerpt"
When does Azenta, Inc. report earnings?
Azenta, Inc.'s next earnings report is expected on 2026-11-17.

Every figure on this page comes from Azenta, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.